Close

Chimerix, Inc. (CMRX) Reports Emergency IND for Brincidofovir Authorized by FDA for Patients With Ebola Virus Disease

October 6, 2014 8:05 AM EDT Send to a Friend
Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login